Acinetobacter baumannii: Susceptibility of strains identified in the military instruction hospital Mohammed V, Rabat, Morocco;Acinetobacter baumannii: Étude de la sensibilité des souches isolées à l'hôpital militaire d'instruction Mohammed V, Rabat, Maroc

Medecine et Maladies Infectieuses

Volumn 33, Issue 7, 2003, Pages 361-364

  Elouennas, M ^a,b   Bajou, T ^a   Lemnouer, A H ^a   Foissaud, V ^b   Herve V ^b   Baaj, A J ^a  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

^b PERCY MILITARY HOSPITAL   (France)

Author keywords

Acinetobacter baumannii; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INTENSIVE CARE; MAJOR CLINICAL STUDY; NONHUMAN; STRAIN IDENTIFICATION;

EID: 0038502405     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(03)00205-1     Document Type: Article

References (8)

1. Bouvet PJM. Joly-Guillou ML. Acinetobacter. In: Freny J, Renaud F, Hansen W, Bollet C, editors. Précis de Bactériologie Clinique. Paris: Eska; 2000. p. 1239-58.
2. Bouvet PJM, Grimont PAD. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur/Microbiology 1987;138: 569-78.
3. Bull Soc Fr Microbiol 1993;8:156-66. Clin Microbiol Infect 1996; 2(Suppl. 1).
4. Bull Soc Fr Microbiol 1993;8:156-66. Clin Microbiol Infect 1996; 2(Suppl. 1).
5. Elouennass M, Bajjou T, Baaj AJ. Infection à Acinetobacter en milieu hospitalier. Biologie Infectiologie 2001;Tome VII(N° 1):5-15.
6. Manikal VM, Landman D, Saurina G, Oydina Elyse, Lai H, Quale J. Endemic carbapenem-resistant Acinetobacter species in broklyn, New York: city wide, prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect dis 2000;31:101-6.
7. Joly-Guillou ML. Acinetobacter baumannii: sensibilité actuelle aux antibiotiques - mécanismes de résistance-fréquence. La lettre de l'infectiologue 1997;tome XII(N° 9):399-404.
8. Heinemann B, Wisplinghoff H, Edmond M, Seifert H. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains. Antimicrob Agents Chemother 2000;44:2211-3.